Company Filing History:
Years Active: 1986
Title: Giora Davidovits: Innovating Leukocyte Detection in Brookline, MA
Introduction
Giora Davidovits is a notable inventor based in Brookline, Massachusetts, recognized for his contributions to the field of leukocyte research. With a focus on advancing methods for detecting the phagocytic and killing abilities of leukocytes, he has made significant strides in improving diagnostics and research methodologies.
Latest Patents
Davidovits holds one patent titled "Simultaneous detection of leukocyte phagocytic and killing ability." This innovative patent outlines methods for determining the phagocytic and killing capabilities of selected leukocyte subclasses. The process involves utilizing three-part differentials derived from light scatter characteristics and gated fluorescence, employing particles that possess multiple fluorescent labels—one sensitive to reactive oxygen. The detection of these fluorescent labels enables the identification of cells that exhibit phagocytic abilities, as indicated by the presence of a non-sensitive label, as well as those capable of killing, determined by a decrease in fluorescence from the sensitive label.
Career Highlights
Giora Davidovits is affiliated with Ortho Diagnostics Systems, Inc., where he applies his expertise to further advancements in diagnostic technologies. His work has provided valuable insights that enhance the understanding of leukocyte functions, potentially leading to improved clinical outcomes in various medical conditions.
Collaborations
Throughout his career, Davidovits has collaborated with colleagues such as Stefan J Kirchanski and Robert A Hoffman. These partnerships have facilitated the sharing of knowledge and expertise, driving innovation and fostering advancements in their respective fields.
Conclusion
Giora Davidovits exemplifies the spirit of innovation in the scientific community. His contributions to leukocyte detection and research methods reflect a commitment to enhancing medical diagnostics and understanding immune responses. With a focus on research and collaboration, Davidovits continues to contribute to advancements in his field.